ACOTEC-B (06669): Venous Intracavitary Radiofrequency Ablation System Receives FDA 510(K) Market Clearance
Stock News
Oct 09
ACOTEC-B (06669) announced that on October 7, 2025, the company's venous intracavitary radiofrequency ablation system received 510(k) market clearance from the U.S. Food and Drug Administration. The system includes the Cedar™ venous intracavitary radiofrequency catheter and venous intracavitary radiofrequency generator, which work together to treat lower limb varicose veins caused by superficial venous reflux. The company has signed a distribution agreement with a member company of the BSC Group for the product's sales in the United States. BSC Group will commence commercialization efforts for this product in the U.S. market in due course.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.